Home › NCT07464574

Optimizing Non-statin Agents for ASCVD

Using Pharmacy Extenders to Optimize Non-statin Agents for Secondary ASCVD Prevention Outcomes in a Federally Qualified Health Center

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Adult patients (\>18 years) who have seen a CommUnityCare provider in the previous 12 months at time of enrollment, who have a documented history of clinical ASCVD, and are not achieving LDL targets (either \<55 or \<70 mg/dL based on risk factors)

Exclusion Criteria:

* Patients will be excluded if they do not have a clearly documented history clinical ASCVD, are already achieving LDL targets (either \<55 or \<70 mg/dL based on risk factors), having cholesterol managed by outside provider (e.g. outside cardiologist/lipid specialist), current pregnancy, have not seen a CUC provider in the previous 12 months, or otherwise do not qualify for clinical pharmacy intervention

About the study

* The purpose of the study is to improve care for patients with high cholesterol. * If you choose to join the study, you will be asked to answer a phone call from study personnel. They will help you coordinate follow up appointments, review your medications and lab with you, and answer any questions you have about your medications. You will also continue to be seen by a clinical pharmacy team member. Your cholesterol medications may change to better lower your cholesterol. We will collect information about your visits, medicines, and cholesterol levels for 6 months. * If you choose not to participate, you will receive the same information and treatment at your next scheduled visit. You will receive the same care regardless of choosing to participate in the study. * Participation might involve a very low risk of some loss of privacy. There is low risk that someone outside the research study could see information about you. * A possible benefit is lower cholesterol. * Taking part in this research study is your choice. You do not have to participate, and you can stop at any time without any penalty.

What is being tested

• Pharmacy Intern Counseling (behavioral)

Sponsor: University of Texas at Austin · Participants: 1,000 · Started: Jan 16, 2026

Contact the study team

• Morgan Stewart, PharmD · Phone: 5129789096
• Kathryn Lin, PharmD · Phone: 512-978-8593

Official record on ClinicalTrials.gov — NCT07464574

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.